Updated:
Shanghai Junrui Investment
Shanghai Junrui Investment is a asset manager based in Shanghai; the Altss profile covers its classification, headquarters, registration, AUM band, and key...
Shanghai Junrui Investment
Shanghai Junrui Investment is a Shanghai-based investment company with a focus on Asia. It has committed to six funds.
General information
Firm type
Generalist
Location
Region
Asia
Country
China
City
Shanghai
Corporate office
Shanghai, China
Principals
Wu Hao
Founder
Ding Kai
Executive
Ding Bo
Executive
Sector focus
Frequently asked questions
How is Shanghai Junrui Investment connected to Mindray Bio-Medical Electronics?
The firm was founded by Wu Hao, who serves as CEO of Shenzhen-listed Mindray. Junrui invests capital linked to Mindray's ecosystem, and its deal flow is influenced by Mindray's position as a major medical device manufacturer. This gives the firm an industrial sourcing advantage distinct from third-party venture capital managers.
What investment stages does Shanghai Junrui Investment target?
Junrui is generalist in its stage coverage, writing checks from seed and start-up phases through expansion and growth equity. It does not publicly restrict itself to a single stage band, allowing the firm to follow portfolio companies as they scale.
Does Shanghai Junrui Investment co-invest with external partners?
Yes. Han Century Capital is a known co-investor and has partnered with Junrui through dedicated vehicles such as Ningbo Han Century Junrui. The firm's deal structures accommodate both direct investments and co-investment fund formats alongside trusted partners.
Who runs investment decisions at Shanghai Junrui Investment?
Founder Wu Hao is the key decision-maker, with business partners Ding Kai and Ding Bo holding executive and shareholder roles across Junrui entities. The group operates with a lean principal-driven structure and does not maintain a public-facing team of investment professionals beyond the core partners.
Which sectors does Shanghai Junrui Investment focus on?
The firm invests across healthcare services, enterprise software, and industrial technology. The healthcare focus aligns with founder Wu Hao's operational background at Mindray, where patient monitoring and diagnostics are core product lines that provide sector-specific technical diligence benefits.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on asset managers?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: